4Blumberg FC, Rieqqer CA, Pfeifer M. Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise [J]. Chest, 2002,121(5) :1566-1571.
5Vrause W, Krais T. Phannscokinetice and pharmascodynamic of the prostacyclin analogue, iloprostin man [J]. Br J Clin Med,2002, 347 (5) :32-34.
6Archer SL, Mike D, Crow J, et al. A placebo-controlled trial of prostacyelin in acute respiratory failure in COPD. Chest, 1996,109: 750-755.
7McCormack D. Vasodilator therapy in acute respiratory failure. Chest, 1996,109:596-597.
8Dominguez Z,Merhi soussi F,MacOvschi O,et al.Endothelial cell prostacyclin synthesis induced by lymphocytes is independent of the membrane fatty acid composition of both cell types and of E-selectin,VCAM-1 or ICAM-1-mediated adhesion[J].Br J Haematol,2001,113(2):521-532.
9Oravec S,Demuth K,Myara I,et al.The effect of high density lipoprotein subfractions on endothelial eicosanoid secretion[J].Thromb Res,1998,92(2):65-71.
10Okahara K,Sun B,Kambayashi J.Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells[J].Arterioscler Thromb Vasc Biol,1998,18(12):1922-1926.
